Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rojas Fernandez, Alejandro ^a   Herhaus, Lina ^a   Macartney, Thomas ^a   Lachaud, Christophe ^a   Hay, Ronald T ^a   Sapkota, Gopal P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GFR PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; GENETIC TRANSCRIPTION; GENETICS; HUMAN; PROMOTER REGION; REPORTER GENE; TRANSGENE; TUMOR CELL LINE;

CELL LINE, TUMOR; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; GENES, REPORTER; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 84928974851     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09811     Document Type: Article

References (37)

1. Kelkar, M. & De, A. Bioluminescence based in vivo screening technologies. Curr. Opin. Pharmacol. 12, 592-600, doi:10. 1016/j. coph. 2012. 07. 014 (2012).
2. Michelini, E., Cevenini, L., Mezzanotte, L., Coppa, A. & Roda, A. Cell-based assays: fuelling drug discovery. Anal. Bioanal. Chem. 398, 227-238, doi:10. 1007/ s00216-010-3933-z (2010).
3. Bonora, G., Plath, K. & Denholtz, M. A mechanistic link between gene regulation and genome architecture in mammalian development. Curr. Opin. Genet. Dev. 27C, 92-101, doi:10. 1016/j. gde. 2014. 05. 002 (2014).
4. Smallwood, A. & Ren, B. Genome organization and long-range regulation of gene expression by enhancers. Curr. Opin. Cell Biol. 25, 387-394, doi:10. 1016/ j. ceb. 2013. 02. 005 (2013).
5. Fanucchi, S., Shibayama, Y., Burd, S., Weinberg, M. S. & Mhlanga, M. M. Chromosomal contact permits transcription between coregulated genes. Cell 155, 606-620, doi:10. 1016/j. cell. 2013. 09. 051 (2013).
6. Dekker, J., Marti-Renom, M. A. & Mirny, L. A. Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat. Rev. Genet. 14, 390-403, doi:10. 1038/nrg3454 (2013).
7. Kain, S. R. & Ganguly, S. Overview of genetic reporter systems. Curr. Protoc. Mol. Biol. 68, II:9. 6, 9. 6. 1-9. 6. 12. (2001).
8. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823, doi:10. 1126/science. 1231143 (2013).
9. Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827-832, doi:10. 1038/nbt. 2647 (2013).
10. Makarova, K. S. et al. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467-477, doi:10. 1038/nrmicro2577 (2011).
11. Makarova, K. S., Wolf, Y. I., Snir, S. & Koonin, E. V. Defense islands in bacterial and archaeal genomes and prediction of novel defense systems. J. Bacteriol. 193, 6039-6056, doi:10. 1128/JB. 05535-11 (2011).
12. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826, doi:10. 1126/science. 1232033 (2013).
13. Keeton, M. R., Curriden, S. A., van Zonneveld, A. J. & Loskutoff, D. J. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem. 266, 23048-23052 (1991).
14. Balta, G., Altay, C. & Gurgey, A. PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am. J. Hematol. 71, 89-93, doi:10. 1002/ ajh. 10192 (2002).
15. Wang, S. et al. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis. PloS one 8, e56797, doi:10. 1371/ journal. pone. 0056797 (2013).
16. Ha, H., Oh, E. Y. &Lee, H. B. The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nat. Rev. Nephrol. 5, 203-211, doi:10. 1038/ nrneph. 2009. 15 (2009).
17. Mehta, R. & Shapiro, A. D. Plasminogen activator inhibitor type 1 deficiency. Haemophilia 14, 1255-1260, doi:10. 1111/j. 1365-2516. 2008. 01834. x (2008).
18. Hu, J. et al. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res. 42, 4375-4390, doi:10. 1093/nar/gku109 (2014).
19. Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370-1379, doi:10. 1016/j. cell. 2013. 08. 022 (2013).
20. Zheng, Q. et al. Precise gene deletion and replacement using theCRISPR/Cas9 system in human cells. BioTechniques 57, 115-124, doi:10. 2144/000114196 (2014).
21. Bottcher, R. et al. Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res. 42, e89, doi:10. 1093/nar/gku289 (2014).
22. Byrne, S. M., Ortiz, L., Mali, P., Aach, J. & Church, G. M. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. doi:10. 1093/nar/gku1246 (2014).
23. Zhang, C. et al. Efficient editing of malaria parasite genome using the CRISPR/ Cas9 system. mBio 5, e01414-01414, doi:10. 1128/mBio. 01414-14 (2014).
24. Ma, Y. et al. Generation of eGFP and Cre knockin rats by CRISPR/Cas9. FEBS J. 281, 3779-3790, doi:10. 1111/febs. 12935 (2014).
25. Kimura, Y., Hisano, Y., Kawahara, A. & Higashijima, S. Efficient generation of knock-in transgenic zebrafish carrying reporter/driver genes by CRISPR/ Cas9-mediated genome engineering. Sci. Rep. 4, 6545, doi:10. 1038/srep06545 (2014).
26. Friedland, A. E. et al. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat. Methods 10, 741-743, doi:10. 1038/nmeth. 2532 (2013).
27. Cho, S. W., Lee, J., Carroll, D., Kim, J. S. & Lee, J. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics 195, 1177-1180, doi:10. 1534/genetics. 113. 155853 (2013).
28. Katic, I. & Grosshans, H. Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans. Genetics 195, 1173-1176, doi:10. 1534/ genetics. 113. 155754 (2013).
29. Tzur, Y. B. et al. Heritable custom genomic modifications in Caenorhabditis elegans via a CRISPR-Cas9 system. Genetics 195, 1181-1185, doi:10. 1534/ genetics. 113. 156075 (2013).
30. Waaijers, S. et al. CRISPR/Cas9-targeted mutagenesis in Caenorhabditis elegans. Genetics 195, 1187-1191, doi:10. 1534/genetics. 113. 156299 (2013).
31. Li, K., Wang, G., Andersen, T., Zhou, P. & Pu, W. T. Optimization of genome engineering approaches with the CRISPR/Cas9 system. PloS one 9, e105779, doi:10. 1371/journal. pone. 0105779 (2014).
32. Munoz, I. M., Szyniarowski, P., Toth, R., Rouse, J. & Lachaud, C. Improved genome editing in human cell lines using the CRISPR method. PLoS one 9, e109752, doi:10. 1371/journal. pone. 0109752 (2014).
33. Lee, C.-C. & Huang, T.-S. Plasminogen activator inhibitor-1: the expression, biological functions, and effects on tumorigenesis and tumor cell adhesion and migration J. Cancer Mol. 1, 25-36 (2005).
34. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 (1976).
35. Herhaus, L. et al. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. Open Biol. 4, 140065, doi:10. 1098/ rsob. 140065 (2014).
36. Herhaus, L., Al-Salihi, M., Macartney, T., Weidlich, S. & Sapkota, G. P. OTUB1 enhances TGFb signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat. Commun. 4, 2519, doi:10. 1038/ncomms3519 (2013).
37. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).